VIRTUAL SCREENING OF PHYTOCHEMICALS FOR METHOTREXATE LIKE DIHYDROFOLATE REDUCTASE AND AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE (AICAR) TRANSFORMYLASE INHIBITORY PROPERTY USING MOLEGRO VIRTUAL DOCKER
Abstract
Objective: Methotrexate is an effective treatment for autoimmune diseases like Rheumatoid arthritis, vasculitis, and Psoriasis. Our aim is to do in silico screening of various phytochemicals present in common medicinal plants used in India for arthritis and fever for possible Dihydrofolate reductase (DHFR) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) Transformylase inhibitory property similar to methotrexate (MTX) using molecular docking method.
Methods: We did docking of 142 phytochemicals against DHFR and AICAR Transformylase domain of ATIC (AICAR Transformylase/Inosine monophosphate cyclohydrolase) enzyme structures extracted from Protein Data Bank (4M6K, 1P4R respectively), by utilizing the Molegro virtual docker Software. The docking scores of phytochemicals were compared with the scores of respective native reference ligands present in the crystal structures.
Results: Compounds, dicrocin, melianone, calotropin, uscharidin and mauritine A showed more negative moldoc and rerank scores compared to folic acid and MTX when docked in the folate-binding pocket of DHFR. Dicrocin, melianone and hecogenin showed more negative moldoc and rerank scores compared to scores of AICAR and MTX, when docked in the cavity in AICAR Transformylase, which binds AICAR.
Conclusion: The protein-ligand interaction plays a significant role in structural based drug designing. The present analysis shows that Melianone and dicrocin could be the potential lead molecules for the inhibition of both DHFR and AICAR transformylase like MTX. Uscharidin, calotropin, and mauritine A may be the potential DHFR inhibitor lead molecules and Hecogenin could be the potential lead molecule for inhibition of AICAR transformylase.
Keywords: Dihydrofolate reductase, AICAR Transformylase, Melianone, Hecogenin, Mauritine A
Downloads
References
Seeger DR, Cosulich DB, Smith JM, Hultquist ME. Analogs of pteroylglutamic acid. III. 4-amino derivatives. J Am Chem Soc 1949;71:1753–8.
Beutler E, Williams WJ. Williams hematology. 8th ed. McGraw-Hill: New York: 2010.
Brunton L, Chabner B, Knollman B, Goodman. Gilman’s the Pharmacological Basis of therapeutics. 12th edition. McGraw-Hill, New York; 2013.
Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002;4:266-73.
Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci 1951;221:176–82.
Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991;88:2441–5.
Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92:2675–82.
Montesinos MC, Desai A, Delano D, Chen JF, Fink JS, Jacobson MA, et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum 2003;48:240–7.
Kremer JM, Hamilton RA. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg. J Rheumatol 1995;22:2072–7.
Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994;121:833–41.
Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem 2006;49:3315–21.
Rayl EA, Moroson BA, Beardsley GP. The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping. J Biol Chem 1996;271:2225–33.
Greasley SE, Horton P, Ramcharan J, Beardsley GP, Benkovic SJ, Wilson IA. Crystal structure of a bifunctional transformylase and cyclohydrolase enzyme in purine biosynthesis. Nat Struct Biol 2001;8:402–6.
Wolan DW, Greasley SE, Beardsley GP, Wilson IA. Structural insights into the avian AICAR transformylase mechanism. Biochemistry 2002;41:15505–13.
Wolan DW, Greasley SE, Wall MJ, Benkovic SJ, Wilson IA. The structure of avian AICAR transformylase with a multisubstrate adduct inhibitor beta-DADF identifies the folate binding site. Biochemistry 2003;42:10904–14.
Bulock KG, Beardsley GP, Anderson KS. The kinetic mechanism of the human bifunctional enzyme ATIC (5-amino-4-imidazolecarboxamide ribonucleotide transformylase/inosine 5’-monophosphate cyclohydrolase). A surprising lack of substrate channeling. J Biol Chem 2002;277:22168–74.
Wilson E, Rajamanickam GV, Vyas N, Agarwal A, Dubey GP. Herbs used in Siddha medicine for arthritis-A review. Indian J Traditional Knowledge 2007;6:678-86.
Subbarayappa B. Siddha medicine: an overview. Lancet Elsevier 1997;350:1841–4.
Umashanker M, Shruti S. Traditional Indian herbal medicine used as antipyretic, antiulcer, antidiabetic and anticancer: a review. Int J Res Pharm Chem 2011;1:1152-9.
S Bhavani. Review on antipyretic and analgesic herbs in siddha medicine. J Pharm Sci Res 2015;7:812-7.
Yang JM, Chen CC. GEMDOCK: a generic evolutionary method for molecular docking. Proteins 2004;55:288–304.
Cody V, Luft JR, Pangborn W. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH. Acta Crystallogr Sect D: Biol Crystallogr 2005; 61:147–55.
Osborne MJ, Schnell J, Benkovic SJ, Dyson HJ, Wright PE. Backbone dynamics in dihydrofolate reductase complexes: role of loop flexibility in the catalytic mechanism. Biochemistry 2001;40:9846–59.
Klon AE, Héroux A, Ross LJ, Pathak V, Johnson CA, Piper JR, et al. Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 a and 1.05 a resolution. J Mol Biol 2002;320:677–93.
Cheong CG, Wolan DW, Greasley SE, Horton PA, Beardsley GP, Wilson IA, et al. Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates. J Biol Chem 2004;279:18034-45.
Caboni P, NG Ntalli, CE Bueno, LE Alchè. Isolation and chemical characterization of components with biological activity extracted from Azadirachta indica and Melia azedarach. ACS Symp Ser 2012;4:51–77.
Vardhini RS. Insilico analysis of protein-ligand docking of DHFR (Dihydro Folate Reductase) and quassinoids. Int J Computer Appl 2013;62:14.
Mirunalini S, Karthishwaran K, Vaithiyanathan V. Antiproliferative potential of pergularia daemia (forsk.) On human oral epidermoid carcinoma (kb) cells by inducing apoptosis and modifying oxidant-antioxidant status. Asian J Pharm Clin Res 2014;7:89-95.
Kupchan SM, Knox JR, Kelsey JE, Saenzrenauld JA. Calotropin, a cytotoxic principle isolated from Asclepias Curassavica L. Science 1964;146:1685–6.
Huang X, Kojima-Yuasa A, Norikura T, Kennedy DO, Hasuma T, Matsui-Yuasa I. Mechanism of the anti-cancer activity of Zizyphus jujuba in HepG2 cells. Am J Chin Med 2007;35:517–32.
Kumar S, Ganachari MS, Nagoor VS. Anti-inflammatory activity of Ziziphus jujuba Lam leaves extract in rats. J Nat Rem 2004;4:183-5.
Quintans JSS, Barreto RSS, de Lucca W, Villarreal CF, Kaneto CM, Soares MBP, et al. Evidence for the involvement of spinal cord inhibitory and cytokines-modulatory mechanisms in the anti-hyperalgesic effect of hecogenin acetate, a steroidal sapogenin-acetylated, in mice. Molecules 2014;19:8303–16.